Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Chemotherapy in Unresectable Colorectal Cancer Liver Metastases
NCT00208260Phase 3Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Apr 2004
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of irinotecan, oxaliplatin, fluorouracil and folinic acid in colorectal cancer (CRC) and liver metastasis (5 arms), sponsored by Institut du Cancer de Montpellier. Primary endpoint: Objective Response Rate. Started Apr 2004; status: completed.
02
Drugs
irinotecanoxaliplatinfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)liver metastasis
Beyond the preview
Go deeper on NCT00208260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208260.